Analyst consensus rating
Opko Health Analyst Rating: Buy
Direct answer
Opko Health's consensus rating is Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $4.15.
Forecast evidence checked November 14, 2026.
Get free Opko Health email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.68
- Average price target
- $4.15
- High price target
- $8.50
- Low price target
- $2.25
- Low target gap
- +33.9%
- Target upside
- +147%
- High target gap
- +406%
- Target range width
- 372%
- Consensus rating
- Buy
- Analysts
- 5
- Evidence date
- November 14, 2026
- Valid through
- November 21, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Opko Health?
Opko Health has a verified Buy consensus. The same dataset has an average price target of $4.15.
How far are Opko Health's low and high targets from the recorded price?
The low target implies +33.9%, while the high target implies +406%.
How many analysts are included in Opko Health's consensus?
The verified consensus includes 5 analysts.
How is Opko Health's target upside or downside calculated?
The average target of $4.15 is divided by the recorded price of $1.68, then one is subtracted to produce +147%. This does not guarantee a future return.
When was Opko Health's analyst forecast verified?
The data was verified on 2026-11-14. The dataset is valid through 2026-11-21.